These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats. Schwetz I; McRoberts JA; Coutinho SV; Bradesi S; Gale G; Fanselow M; Million M; Ohning G; Taché Y; Plotsky PM; Mayer EA Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G704-12. PubMed ID: 15994424 [TBL] [Abstract][Full Text] [Related]
5. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats. Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287 [TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Saito-Nakaya K; Hasegawa R; Nagura Y; Ito H; Fukudo S Neurogastroenterol Motil; 2008 Oct; 20(10):1147-56. PubMed ID: 18761632 [TBL] [Abstract][Full Text] [Related]
7. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Nakade Y; Fukuda H; Iwa M; Tsukamoto K; Yanagi H; Yamamura T; Mantyh C; Pappas TN; Takahashi T Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1037-44. PubMed ID: 17158256 [TBL] [Abstract][Full Text] [Related]
8. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. Martínez V; Rivier J; Wang L; Taché Y J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of oxytocin on accelerated colonic motility induced by water-avoidance stress in rats. Matsunaga M; Konagaya T; Nogimori T; Yoneda M; Kasugai K; Ohira H; Kaneko H Neurogastroenterol Motil; 2009 Aug; 21(8):856-e59. PubMed ID: 19298230 [TBL] [Abstract][Full Text] [Related]
10. Excitatory stimulation of neurons in the arcuate nucleus initiates central CRF-dependent stimulation of colonic propulsion in rats. Tebbe JJ; Pasat IR; Mönnikes H; Ritter M; Kobelt P; Schäfer MK Brain Res; 2005 Mar; 1036(1-2):130-8. PubMed ID: 15725410 [TBL] [Abstract][Full Text] [Related]
11. Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats. Verleye M; Gillardin JM Physiol Behav; 2004 Oct; 82(5):891-7. PubMed ID: 15451655 [TBL] [Abstract][Full Text] [Related]
12. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems. Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598 [TBL] [Abstract][Full Text] [Related]
13. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior. Bruijnzeel AW; Stam R; Wiegant VM Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086 [TBL] [Abstract][Full Text] [Related]
14. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282 [TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal. Vining C; Iyer V; Bhatnagar S J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593 [TBL] [Abstract][Full Text] [Related]
16. Visceral hypersensitivity in irritable bowel syndrome. Kanazawa M; Hongo M; Fukudo S J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723 [TBL] [Abstract][Full Text] [Related]
17. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Taché Y; Martinez V; Million M; Maillot C Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197 [TBL] [Abstract][Full Text] [Related]
18. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643 [TBL] [Abstract][Full Text] [Related]
19. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Bondi CO; Barrera G; Lapiz MD; Bedard T; Mahan A; Morilak DA Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):482-95. PubMed ID: 17188790 [TBL] [Abstract][Full Text] [Related]
20. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats. McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]